Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model

被引：0
|
作者：
Pascal Crépey
Louis Boiron
Rafael Rodrigo Araujo
Juan Guillermo Lopez
Audrey Petitjean
Expedito José de Albuquerque Luna
机构：
[1] University of Rennes,Department of Quantitative Methods in Public Health, UPRES
[2] Sanofi Pasteur,EA
[3] Sanofi Pasteur,7449 Reperes, EHESP
[4] Sanofi Pasteur,undefined
[5] Institute of Tropical Medicine (IMT) - University of São Paulo (USP),undefined
来源：
BMC Public Health | / 20卷
关键词：
QIV; Quadrivalent; Public health; Cost-effectiveness; Vaccine; Influenza; Brazil;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Impact of quadrivalent influenza vaccines in Brazil: a cost-effectiveness analysis using an influenza transmission model
    Crepey, Pascal
    Boiron, Louis
    Araujo, Rafael Rodrigo
    Lopez, Juan Guillermo
    Petitjean, Audrey
    de Albuquerque Luna, Expedito Jose
    [J]. BMC PUBLIC HEALTH, 2020, 20 (01)
  • [2] Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
    Dominic Thorrington
    Edwin van Leeuwen
    Mary Ramsay
    Richard Pebody
    Marc Baguelin
    [J]. BMC Medicine, 15
  • [3] Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in England
    Thorrington, Dominic
    van Leeuwen, Edwin
    Ramsay, Mary
    Pebody, Richard
    Baguelin, Marc
    [J]. BMC MEDICINE, 2017, 15
  • [4] Cost-effectiveness analysis of quadrivalent seasonal influenza vaccines in Beijing: A modeling analysis
    Zhu, Dawei
    Lv, Min
    Bai, Yunhua
    Wu, Jiang
    He, Ping
    [J]. VACCINE, 2022, 40 (07) : 994 - 1000
  • [5] COST-EFFECTIVENESS OF QUADRIVALENT VERSUS TRIVALENT INFLUENZA VACCINES FOR CHILDREN
    Yang, M. C.
    Tan, C. H.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A161 - A161
  • [6] An Assessment of the Expected Cost-Effectiveness of Quadrivalent Influenza Vaccines in Ontario, Canada Using a Static Model
    Chit, Ayman
    Roiz, Julie
    Aballea, Samuel
    [J]. PLOS ONE, 2015, 10 (07):
  • [7] COST-EFFECTIVENESS ANALYSIS OF QUADRIVALENT INFLUENZA VACCINE IN SPAIN
    Garcia Rojas, A.
    Ortiz de Lejarazu, R. L.
    Reina, J.
    Callejo, D.
    Cuervo Uria, J.
    Morano Larragueta, R.
    [J]. VALUE IN HEALTH, 2015, 18 (07) : A588 - A588
  • [8] Cost-effectiveness analysis of quadrivalent influenza vaccine in Spain
    Garcia, Amos
    Ortiz de Lejarazu, Raul
    Reina, Jordi
    Callejo, Daniel
    Cuervo, Jesus
    Morano Larragueta, Raul
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (09) : 2269 - 2277
  • [9] Switching from trivalent to quadrivalent inactivated influenza vaccines in Uruguay: a cost-effectiveness analysis
    Bianculli, Pablo Manuel
    Bellier, Lucile
    Mangado, Ignacio Olivera
    Perez, Carlos Grau
    Mieres, Gustavo
    Lazarov, Luis
    Petitjean, Audrey
    Dibarboure, Hugo
    Lopez, Juan Guillermo
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (05)
  • [10] Review of seasonal influenza in Canada: Burden of disease and the cost-effectiveness of quadrivalent inactivated influenza vaccines
    Thommes, Edward W.
    Kruse, Morgan
    Kohli, Michele
    Sharma, Rohita
    Noorduyn, Stephen G.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2017, 13 (04) : 867 - 876
12345